110 related articles for article (PubMed ID: 35753742)
21. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
22. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.
Meng ZW; Han SH; Zhu JH; Zhou LY; Chen YL
World J Surg; 2017 Mar; 41(3):835-843. PubMed ID: 27766397
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.
Hong ZF; Zhang WQ; Wang SJ; Li SY; Shang J; Liu F; Shen DY
Biomed Pharmacother; 2020 Mar; 123():109766. PubMed ID: 31846841
[TBL] [Abstract][Full Text] [Related]
25. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.
Martini A; Prasai K; Zemla TJ; Ahmed FY; Elnagar MB; Giama NH; Guzzardo V; Biasiolo A; Fassan M; Yin J; Pontisso P; Roberts LR
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201652
[TBL] [Abstract][Full Text] [Related]
26. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
[TBL] [Abstract][Full Text] [Related]
27. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
[TBL] [Abstract][Full Text] [Related]
28. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
[TBL] [Abstract][Full Text] [Related]
29. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma.
Meng FT; Huang M; Shao F; Huang Q
Cancer Biomark; 2018; 23(3):353-361. PubMed ID: 30248044
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center.
Li J; Chen Q; Jin B; Shi Y; Wu X; Xu H; Zheng Y; Wang Y; Du S; Lu X; Mao Y; Sang X
Cancer Manag Res; 2020; 12():411-417. PubMed ID: 32021453
[TBL] [Abstract][Full Text] [Related]
31. Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.
You MS; Lee SH; Kang J; Choi YH; Choi JH; Shin BS; Huh G; Paik WH; Ryu JK; Kim YT; Jang DK; Lee JK
Gut Liver; 2019 May; 13(3):373-379. PubMed ID: 30600674
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer.
Feng L; Gu S; Wang P; Chen H; Chen Z; Meng Z; Liu L
Cancer Med; 2018 Dec; 7(12):5943-5951. PubMed ID: 30474926
[TBL] [Abstract][Full Text] [Related]
33. Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.
Deng Y; Chen Y
Oncol Res Treat; 2017; 40(3):128-132. PubMed ID: 28118648
[TBL] [Abstract][Full Text] [Related]
34. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors.
Dageforde LA; Vachharajani N; Tabrizian P; Agopian V; Halazun K; Maynard E; Croome K; Nagorney D; Hong JC; Lee D; Ferrone C; Baker E; Jarnagin W; Hemming A; Schnickel G; Kimura S; Busuttil R; Lindemann J; Florman S; Holzner ML; Srouji R; Najjar M; Yohanathan L; Cheng J; Amin H; Rickert CA; Yang JD; Kim J; Pasko J; Chapman WC; Majella Doyle MB
J Am Coll Surg; 2021 Apr; 232(4):361-371. PubMed ID: 33316425
[TBL] [Abstract][Full Text] [Related]
35. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.
Zhao JG; Hu Y; Liao Q; Niu ZY; Zhao YP
World J Gastroenterol; 2014 May; 20(19):5875-80. PubMed ID: 24914348
[TBL] [Abstract][Full Text] [Related]
37. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.
Wang H; Liu W; Tian M; Tang Z; Jiang X; Zhou P; Ding Z; Peng Y; Dai Z; Qiu S; Zhou J; Fan J; Shi Y
Biosci Trends; 2017 Sep; 11(4):469-474. PubMed ID: 28781265
[TBL] [Abstract][Full Text] [Related]
38. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
39. Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000.
Salgia RJ; Singal AG; Fu S; Pelletier S; Marrero JA
Dig Dis Sci; 2014 May; 59(5):1048-54. PubMed ID: 23504331
[TBL] [Abstract][Full Text] [Related]
40. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
